Dentsply Sirona Q4 Loss Narrows
XRAY sits 39% above its 52-week low of $9.85.
Summary
Dentsply Sirona reported fourth-quarter results showing a significant narrowing of its net loss to $146 million ($0.74 per share) from $430 million ($2.16 per share) in the prior year. The company also saw a slight increase in adjusted earnings per share to $0.27 from $0.26, and sales grew to $961 million from $905 million year-over-year. For the full year 2026, Dentsply Sirona expects net sales between $3.5 billion and $3.6 billion, with adjusted earnings per share in the range of $1.40 to $1.50. These results indicate improving financial performance and provide forward-looking expectations for investors. Traders will be assessing these figures against analyst consensus and prior guidance to determine the stock's immediate direction.
At the time of this announcement, XRAY was trading at $13.65 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.5B. The 52-week trading range was $9.85 to $19.17. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: dpa-AFX.